Qualigen Receives FDA Clearance for its FastPack® IP SHBG Assay

Wednesday, January 30, 2019 Men´s Health News
Email Print This Page Comment bookmark
Font : A-A+

CARLSBAD, Calif., Jan. 29, 2019 /PRNewswire/ -- Qualigen, Inc., a privately-owned company that provides novel diagnostic

and therapeutic technologies for the treatment of cancer and infectious diseases, today announced that the Company has received clearance from the U.S. Food and Drug Administration for its FastPack IP Sex Hormone Binding Globulin (SHBG) Immunoassay. 
Sex Hormone Binding Globulin is an important biomarker used in the diagnosis and treatment of men's health.  "FastPack IP SHBG provides rapid, fully-quantitative and highly accurate Sex Hormone Binding Globulin results to clinicians and patients," stated Dr. Wajdi Abdul-Ahad, Qualigen's Vice President of Assay Development, whose team developed this assay.  "We are pleased to continue the expansion of our novel FastPack product line and to provide additional diagnostic tools to our physicians and their patients," added Michael S. Poirier, Chief Executive Officer of Qualigen.

About Qualigen, Inc.Qualigen, Inc. is a medical device company focused on the development, production and commercialization of innovative medical technologies, including its flagship FastPack® point-of-care immunoassay system and novel therapeutic technologies for treatment of cancers and infectious diseases.  For more information, visit www.qualigeninc.com.

© 2019 Qualigen. All rights reserved. Qualigen, the stylized logo, and FastPack are registered trademarks of Qualigen, Incorporated in the United States and other countries.

 

Cision View original content:http://www.prnewswire.com/news-releases/qualigen-receives-fda-clearance-for-its-fastpack-ip-shbg-assay-300786371.html

SOURCE Qualigen, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store